Millipore Sigma Vibrant Logo

565790 γ-Secretase Inhibitor XXI, Compound E - CAS 209986-17-4 - Calbiochem

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
209986-17-4C₂₇H₂₄F₂N₄O₃

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
565790-1MG
Comprobando disponibilidad...
Disponibilidad a confirmar
Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      Frasco de vidrio 1 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      Solicitar precio
      565790-500UG
      Comprobando disponibilidad...
      Disponibilidad a confirmar
Disponibilidad a confirmar
      Ingrese cantidad 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente
          Contact Customer Service

          Ampolla de plást. 500 μg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Maximum Quantity is
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          Description
          OverviewA cell-permeable, potent, selective, peptidomimetic, non-transition-state analog inhibitor of γ-secretase and Notch processing (IC50 = 300 pM for Aβ40 in CHO cells overexpressing wild type βAPP; 240 pM for Aβ40, 370 pM for Aβ42, and 320 pM for NICD, respectively, in HEK293 cells stably transfected with βAPP695 and mNotchΔE(M1727V); 100 pM for both Aβ40 and Aβ42 in SH-SY5Y cells stably transfected with SPA4CT). Lowers Aβ levels in several APP transgenic mouse models. Reported to bind to presenilins and suppress the proteolytic cleavage of transmembrane protein substrates, including APLP1 and APLP2, CD44, ErbB4, E-cadherin, low density lipoprotein receptor-related proteins, Notch ligands, and p75NTR. Only weakly affects presenilinase activity at much higher concentrations (200-400 µM).
          Catalogue Number565790
          Brand Family Calbiochem®
          Synonyms(S,S)- 2-[2-(3,5-Difluorophenyl)-acetylamino]-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionamide, Compound E
          References
          ReferencesMilano, J., et al. 2004. Toxicol. Sci. 82, 341.
          Jung, K.M., et al. 2003. J. Biol. Chem. 278, 42161.
          Murakami, D., et al. 2003. Oncogene 22, 1511.
          Campbell, W.A., et al. 2003. J. Neurochem. 85, 1563.
          Berechid, B.E., et al., 2002. J. Biol. Chem. 277, 8154.
          Lee, H.J., et al. 2002. J. Biol. Chem. 277, 6318.
          May, P., et al. 2002. J. Biol. Chem. 277, 18736.
          Scheinfeld, M.H., et al. 2002. J. Biol. Chem. 277, 44195.
          Ni, C. Y., et al. 2001. Science 294, 2179.
          Beher, D., et al. 2001. J. Biol. Chem. 276, 45394.
          Doerfler, P., et al. 2001. Proc. Natl. Acad. Sci. USA 98, 9312.
          Seiffert, D., et al. 2000. J. Biol. Chem. 275, 34086.
          Product Information
          CAS number209986-17-4
          ATP CompetitiveN
          FormWhite solid
          Hill FormulaC₂₇H₂₄F₂N₄O₃
          Chemical formulaC₂₇H₂₄F₂N₄O₃
          ReversibleN
          Structure formula ImageStructure formula Image
          Applications
          Biological Information
          Primary Targetγ-secretase and Notch processing Ab40 in CHO cells overexpressing wild type bAPP
          Primary Target IC<sub>50</sub>300 pM for Aβ40 in CHO cells overexpressing wild typeβAPP; 240 pM for Aβ40, 370 pM for Aβ42, and 320 pM for NICD, respectively, in HEK293 cells stably transfected with βAPP695 and mNotchΔE(M1727V); 100 pM for both Aβ40
          Purity≥95% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          Número de referencia GTIN
          565790-1MG 04055977191851
          565790-500UG 04055977191868

          Documentation

          γ-Secretase Inhibitor XXI, Compound E - CAS 209986-17-4 - Calbiochem Ficha datos de seguridad (MSDS)

          Título

          Ficha técnica de seguridad del material (MSDS) 

          γ-Secretase Inhibitor XXI, Compound E - CAS 209986-17-4 - Calbiochem Certificados de análisis

          CargoNúmero de lote
          565790

          Referencias bibliográficas

          Visión general referencias
          Milano, J., et al. 2004. Toxicol. Sci. 82, 341.
          Jung, K.M., et al. 2003. J. Biol. Chem. 278, 42161.
          Murakami, D., et al. 2003. Oncogene 22, 1511.
          Campbell, W.A., et al. 2003. J. Neurochem. 85, 1563.
          Berechid, B.E., et al., 2002. J. Biol. Chem. 277, 8154.
          Lee, H.J., et al. 2002. J. Biol. Chem. 277, 6318.
          May, P., et al. 2002. J. Biol. Chem. 277, 18736.
          Scheinfeld, M.H., et al. 2002. J. Biol. Chem. 277, 44195.
          Ni, C. Y., et al. 2001. Science 294, 2179.
          Beher, D., et al. 2001. J. Biol. Chem. 276, 45394.
          Doerfler, P., et al. 2001. Proc. Natl. Acad. Sci. USA 98, 9312.
          Seiffert, D., et al. 2000. J. Biol. Chem. 275, 34086.
          Ficha técnica

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision04-April-2011 RFH
          Synonyms(S,S)- 2-[2-(3,5-Difluorophenyl)-acetylamino]-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionamide, Compound E
          DescriptionA cell-permeable, potent, selective, peptidomimetic, non-transition-state analog inhibitor of γ-secretase and Notch processing (IC50 = 300 pM for Aβ40 in CHO cells overexpressing wild type βAPP; 240 pM for Aβ40, 370 pM for Aβ42, and 320 pM for NICD, respectively, in HEK293 cells stably transfected with βAPP695 and mNotchΔE(M1727V); 100 pM for both Aβ40 and Aβ42 in SH-SY5Y cells stably transfected with SPA4CT). Lowers Aβ levels in several APP transgenic mouse models. Reported to bind to presenilins and suppress the proteolytic cleavage of transmembrane protein substrates, including APLP1 and APLP2, CD44, ErbB4, E-cadherin, low density lipoprotein receptor-related proteins, Notch ligands, and p75NTR. Only weakly affects presenilinase activity at much higher concentrations (200-400 µM).
          FormWhite solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number209986-17-4
          Chemical formulaC₂₇H₂₄F₂N₄O₃
          Structure formulaStructure formula
          Purity≥95% by HPLC
          SolubilityDMSO (10 mg/ml)
          Storage Protect from light
          +2°C to +8°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Toxicity Standard Handling
          ReferencesMilano, J., et al. 2004. Toxicol. Sci. 82, 341.
          Jung, K.M., et al. 2003. J. Biol. Chem. 278, 42161.
          Murakami, D., et al. 2003. Oncogene 22, 1511.
          Campbell, W.A., et al. 2003. J. Neurochem. 85, 1563.
          Berechid, B.E., et al., 2002. J. Biol. Chem. 277, 8154.
          Lee, H.J., et al. 2002. J. Biol. Chem. 277, 6318.
          May, P., et al. 2002. J. Biol. Chem. 277, 18736.
          Scheinfeld, M.H., et al. 2002. J. Biol. Chem. 277, 44195.
          Ni, C. Y., et al. 2001. Science 294, 2179.
          Beher, D., et al. 2001. J. Biol. Chem. 276, 45394.
          Doerfler, P., et al. 2001. Proc. Natl. Acad. Sci. USA 98, 9312.
          Seiffert, D., et al. 2000. J. Biol. Chem. 275, 34086.